DLBDolby Laboratories, Inc.

$62.88-6.2% 1Y

Is it growing?

Watch

Growth is fading: earnings down −14% year on year and operating margin narrowing (−3.6 points).

2 to watch, 1 neutral
Revenue trend+1% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +1% a year.

Earnings trend−14% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−3.6 points operating

Trailing-twelve-month operating margin, 16.8% now against 20.5% a year earlier.

All from SEC EDGAR, as of Jun 26, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 72% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is DLB growing?

Dolby Laboratories, Inc.'s revenue has grown 1.7% a year over three years, and grown 1.3% a year over five, with earnings per share compounding at 1.3%.

+1.7%

Revenue growth, 3-year annual rate · Specialty Business Services median +8.8% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+1.3%

Revenue growth, 5-year rate · +1.7% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+1.3%

Earnings per share, 3-year rate · revenue +1.7% · earnings lagged revenue: the growth is costing something

Years of annual history on file
18

Years of annual history on file · FY2008 to FY2025, as filed

Details›
Revenue FY2021
$1.28B
Revenue FY2022
$1.25B
Revenue FY2023
$1.30B
Revenue FY2024
$1.27B
Revenue FY2025
$1.35B

Annual income statements as filed with the SEC.